Drug intelligence / Profile preview

Yiqi Sanjie formula

Development stage
Unknown
Lead developer
Shanghai University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Yiqi Sanjie formula is a traditional Chinese medicine (TCM) polyherbal formulation widely used in China for the treatment of various cancers, particularly non-small cell lung cancer (NSCLC) and colorectal cancer. It is typically administered as an adjunct to standard chemotherapy regimens to enhance efficacy and reduce side effects. The formula contains multiple herbal components; key active compounds identified include bifendate, xambioona, hederagenin, and peiminine. Mechanistically, the formula exerts antitumor effects by targeting several molecular pathways involved in cell cycle regulation (notably CCND1/cyclin D1 and CDK4), growth factor signaling (EGFR), apoptosis induction, autophagy modulation, immune response regulation, and possibly metabolic enzymes such as ADH1B. Preclinical studies demonstrate that it can inhibit tumor proliferation and induce apoptosis in cancer cells while reducing chemotherapy-induced toxicity. Clinical evidence supports its use for improving disease-free survival rates in stage III colorectal cancer patients when combined with standard therapies[1][2][3][4][5].

Other names
YQSJYiqi SanJie formulaYQSJF
02

Targets

CCND1 (Cyclin D1)ADH1B (Alcohol dehydrogenase beta-1 subunit)CDK4 (Cyclin-dependent kinase 4)EGFR T790M (Epidermal growth factor receptor T790M mutant)

Beyond the preview

Go deeper on Yiqi Sanjie formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yiqi Sanjie formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call